Blue Bio: Net profit in Q3 2026 was 24.3448 million yuan, down 30.57% year-on-year.

Vland Biotech announced that in the third quarter of 2026, operating revenue was 387 million yuan, up 6.48% year on year; net profit attributable to shareholders of the listed company was 24.3448 million yuan, down 30.57% year on year; net profit after deducting non-recurring gains and losses was 18.9425 million yuan, up 173.29% year on year. In the first three quarters of 2026, operating revenue was 1.097 billion yuan, up 7.97% year on year; net profit attributable to shareholders of the listed company was 62.9045 million yuan, up 1.82% year on year; net profit after deducting non-recurring gains and losses was 41.1068 million yuan, up 79.25% year on year.